179 related articles for article (PubMed ID: 22079749)
1. Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.
Lindemann ML; Dominguez MJ; de Antonio JC; Sandri MT; Tricca A; Sideri M; Khiri H; Ravet S; Boyle S; Aldrich C; Halfon P
J Mol Diagn; 2012 Jan; 14(1):65-70. PubMed ID: 22079749
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of a prototype real-time PCR assay for the separate detection of human papilloma virus genotypes 16 and 18 and other high risk human papillomavirus in cervical cancer screening].
Mateos ML; Chacón de Antonio J; Rodríguez-Domínguez M; Sanz I; Rubio MD
Enferm Infecc Microbiol Clin; 2011; 29(6):411-4. PubMed ID: 21435749
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
4. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.
Stevens MP; Garland SM; Rudland E; Tan J; Quinn MA; Tabrizi SN
J Clin Microbiol; 2007 Jul; 45(7):2130-7. PubMed ID: 17494721
[TBL] [Abstract][Full Text] [Related]
6. Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.
Seme K; Lepej SZ; Lunar MM; Iscić-Bes J; Planinić A; Kocjan BJ; Vince A; Poljak M
J Clin Virol; 2009 Oct; 46(2):176-9. PubMed ID: 19683958
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
[TBL] [Abstract][Full Text] [Related]
8. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
Barzon L; Militello V; Pagni S; Palù G
J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
[TBL] [Abstract][Full Text] [Related]
9. Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.
Ogilvie GS; Cook DA; Taylor DL; Rank C; Kan L; Yu A; Mei W; van Niekerk DJ; Coldman AJ; Krajden M
Vaccine; 2013 Feb; 31(7):1129-33. PubMed ID: 23273510
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
11. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
[TBL] [Abstract][Full Text] [Related]
12. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
13. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
14. Clinical Evaluation of INNO-LiPA HPV Genotyping
Xu L; Padalko E; Oštrbenk A; Poljak M; Arbyn M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208597
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.
Ki EY; Lee YK; Lee A; Park JS
Yonsei Med J; 2018 Jul; 59(5):662-668. PubMed ID: 29869464
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
Yu S; Kwon MJ; Lee EH; Park H; Woo HY
J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study.
Preisler S; Rebolj M; Ejegod DM; Lynge E; Rygaard C; Bonde J
BMC Cancer; 2016 Jul; 16():510. PubMed ID: 27439470
[TBL] [Abstract][Full Text] [Related]
19. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping.
Seme K; Fujs K; Kocjan BJ; Poljak M
J Virol Methods; 2006 Jun; 134(1-2):252-6. PubMed ID: 16417931
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.
Gage JC; Sadorra M; Lamere BJ; Kail R; Aldrich C; Kinney W; Fetterman B; Lorey T; Schiffman M; Castle PE;
J Clin Microbiol; 2012 Jan; 50(1):61-5. PubMed ID: 22075592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]